Risk of cardiovascular disease and loss in life expectancy in NAFLD
Ying Shang, Patrik Nasr, Linnea Widman, Hannes Hagström – 9 April 2022
P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis
- Read more about P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis
Yahui Zhu, Li Gu, Xi Lin, Xinyi Zhou, Bingjun Lu, Cheng Liu, Yajun Li, Edward V. Prochownik, Michael Karin, Fubing Wang, Youjun Li – 9 April 2022
Reply
Vlad Ratziu – 8 April 2022
A standardized immunosuppressive regimen for patients who received liver transplantations treated with atezolizumab–bevacizumab to avoid graft rejection?
Edouard Larrey, Filomena Conti, Manon Allaire – 8 April 2022
Letter to the editor: Regression of liver fibrosis after bariatric operations: A glass two‐third full rather than half empty
François Pattou, Guillaume Lasailly, Violeta Raverdy, Robert Caiazzo, Philippe Mathurin – 7 April 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl‐CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Marta Alonso‐Peña, Ricardo Espinosa‐Escudero, Elisa Herraez, Oscar Briz, Maria Luisa Cagigal, Jesus M. Gonzalez‐Santiago, Aida Ortega‐Alonso, Conrado Fernandez‐Rodriguez, Luis Bujanda, Marta Calvo Sanchez, Delia D´Avola, Maria‐Carlota Londoño, Moises Diago, Jose C. Fernandez‐Checa, Carmen Garcia‐Ruiz, Raul J. Andrade, Frank Lammert, Jesus Prieto, Javier Crespo, Javier Juamperez, Alvaro Diaz‐Gonzalez, Maria J. Monte, Jose J. G. Marin – 7 April 2022
Operational tolerance is not always permanent: A 10‐year prospective study in pediatric liver transplantation recipients
Laura J. Wozniak, Robert S. Venick, Bita V. Naini, Jason Scapa, Michelle J. Hickey, Maura Rossetti, Yael Korin, Elaine F. Reed, Douglas G. Farmer, Ronald W. Busuttil, Jorge H. Vargas, Sue V. McDiarmid – 7 April 2022 – Immunosuppression withdrawal can be safely performed in select liver transplantation recipients, but the long‐term outcomes and sustainability of tolerance have not been well studied.
Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet
Saira Khaderi, Fasiha Kanwal – 6 April 2022
Retuning hepatocytes improves their functional engraftment
Jan S. Tchorz – 6 April 2022
Occludin stalls HCV particle dynamics apart from hepatocyte tight junctions, promoting virion internalization
Maika S. Deffieu, Camille M. H Clément, Cristina M. Dorobantu, Emma Partiot, Yonis Bare, Orestis Faklaris, Benjamin Rivière, Nilda Vanesa Ayala‐Nunez, Thomas F. Baumert, Philippe Rondé, Yves Mély, Vincent Lucansky, Raphael Gaudin – 6 April 2022